Patents by Inventor Per Björntorp

Per Björntorp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7122515
    Abstract: A method for treating a patient having Metabolic Syndrome comprising Primary Insulin Resistance and exhibiting lipoprotein aberrations or hypertension comprises administering to said patient human growth hormone or a functional analog thereof in an amount effective for decreasing lipoprotein aberrations or hypertension of said patient.
    Type: Grant
    Filed: March 25, 2004
    Date of Patent: October 17, 2006
    Assignee: Pharmacia AB
    Inventors: Gudmundur Johannsson, Per M{dot over (a)}rin, Lars Lönn, Malin Ottosson, Kaj Stenlöf, Per Björntorp, Lars Sjöström, Bengt-{dot over (A)}ke Bengtsson
  • Patent number: 6846800
    Abstract: Methods for treating a patient for insulin resistance to decrease the insulin resistance in a patient having Metabolic Syndrome comprising Primary Insulin Resistance and abdominal/visceral obesity comprise administering to the patient growth hormone or a functional derivative thereof in an amount effective for decreasing insulin resistance of the patient.
    Type: Grant
    Filed: March 31, 1998
    Date of Patent: January 25, 2005
    Assignee: Pharmacia AB
    Inventors: Gudmundur Johannsson, Per Mårin, Lars Lönn, Malin Ottosson, Kaj Stenlöf, Per Björntorp, Lars Sjöström, Bengt-Åke Bengtsson